UBS Maintains a 'Buy' on Teva Pharma (TEVA); CEO Highlights From Conference Call
Go back to UBS Maintains a 'Buy' on Teva Pharma (TEVA); CEO Highlights From Conference Call| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 37.42 +0.61 (1.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.81 | 52 Week High | $66.55 | |||
| Open | $36.79 | 52 Week Low | $37.82 | |||
| Day High | $37.75 | P/E | N/A | |||
| Day Low | $36.65 | EPS | $0.00 | |||
| Volume | 2,411,287 | |||||
